Product NDC: | 13537-300 |
Proprietary Name: | Cyzone |
Non Proprietary Name: | Octinoxate, Oxybenzone, and Zinc Oxide |
Active Ingredient(s): | 70; 20; 10 mg/g; mg/g; mg/g & nbsp; Octinoxate, Oxybenzone, and Zinc Oxide |
Administration Route(s): | TOPICAL |
Dosage Form(s): | LIPSTICK |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 13537-300 |
Labeler Name: | Ventura Corporation Ltd. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part352 |
Marketing Category: | OTC MONOGRAPH NOT FINAL |
Start Marketing Date: | 20110228 |
Package NDC: | 13537-300-01 |
Package Description: | 1 TUBE in 1 BOX (13537-300-01) > 4.5 g in 1 TUBE (13537-300-02) |
NDC Code | 13537-300-01 |
Proprietary Name | Cyzone |
Package Description | 1 TUBE in 1 BOX (13537-300-01) > 4.5 g in 1 TUBE (13537-300-02) |
Product NDC | 13537-300 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Octinoxate, Oxybenzone, and Zinc Oxide |
Dosage Form Name | LIPSTICK |
Route Name | TOPICAL |
Start Marketing Date | 20110228 |
Marketing Category Name | OTC MONOGRAPH NOT FINAL |
Labeler Name | Ventura Corporation Ltd. |
Substance Name | OCTINOXATE; OXYBENZONE; ZINC OXIDE |
Strength Number | 70; 20; 10 |
Strength Unit | mg/g; mg/g; mg/g |
Pharmaceutical Classes |